You have 9 free searches left this month | for more free features.

ESA ineligible

Showing 1 - 25 of 453

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

Recruiting
  • Anemia
  • Ferric Derisomaltose Injection
  • Darbepoetin Alfa Injection
  • Anyang-si, Korea, Republic of
    Hallym University Medical Center
Mar 13, 2023

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023

    Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

    Completed
    • Anemia
    • Chula Vista, California
    • +58 more
    Nov 10, 2022

    Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

    Recruiting
    • Plasma Cell Leukemia
    • anti-BCMA CAR-T
    • VRD-based regimen
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Aug 4, 2023

    Hodgkin Lymphoma Trial in Italy (Tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Alessandria, IT, Italy
    • +9 more
    Aug 4, 2023

    Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • +3 more
    • Relmacabtagene Autoleucel
    • +2 more
    • Guangzhou, Guangdong, China
    • +12 more
    Oct 24, 2023

    Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical

    Completed
    • Hemodialysis-Associated Pruritus
    • +4 more
    • Dialysis using the Theranova-400 device.
    • Dialysis using the FX80 device.
    • Şanlıurfa, Karaköprü, Turkey
      Mehmet Akif Inan Training and Research Hospital
    Jan 13, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • VRD
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 5, 2023

    Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

    Suspended
    • Anemia of Chronic Kidney Disease
    • Hackensack, New Jersey
      Research Site
    Aug 23, 2022

    NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)

    Recruiting
    • NMIBC
    • RC48-ADC in Combination with gemcitabine
    • Beijing, Beijing, China
      Peking University First Hosptital
    Jul 10, 2023

    Anemia Associated With Chronic Kidney Disease Trial in United States (Roxadustat)

    Withdrawn
    • Anemia Associated With Chronic Kidney Disease
    • Chicago, Illinois
    • +3 more
    Jun 29, 2022

    Anemia of Chronic Kidney Disease Trial in Hackensack (vadadustat)

    Suspended
    • Anemia of Chronic Kidney Disease
    • Hackensack, New Jersey
      Research Site
    Aug 23, 2022

    Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

    Terminated
    • Urothelial Carcinoma
    • Phoenix, Arizona
    • +7 more
    Dec 15, 2022

    Muscle-Invasive Bladder Carcinoma, Bladder Cancer Trial in Tampa (CG0070, Nivolumab)

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • Bladder Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 11, 2022

    NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

    Recruiting
    • NHL, Adult
    • AML, Adult Recurrent
    • Zhengzhou, Henan, China
    • +1 more
    Feb 24, 2023

    Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Magrolimab
    • +3 more
    • Little Rock, Arkansas
    • +82 more
    Jan 17, 2023

    Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • Cologne, Germany
      University of Cologne
    Oct 14, 2022

    Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

    Recruiting
    • Anemia in Dialysis-dependent CKD Patients
    • Alexandria, Egypt
      Alexandria University
    Oct 29, 2023

    Urinary Bladder Tumors Trial in Worldwide (Durvalumab, Olaparib, Placebo)

    Active, not recruiting
    • Urinary Bladder Neoplasms
    • Birmingham, Alabama
    • +44 more
    Dec 21, 2022

    SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

    Recruiting
    • SCCHN
    • Squamous Cell Carcinoma
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 5, 2023

    Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

    Recruiting
    • Urothelial Cancer
    • Beijing, China
      Beijing Cancer Hospital
    Jan 18, 2023